Depression is common among the elderly but is often underdiagnosed and undertreated. At the same time, there is an inappropriate use of antidepressants within the same elderly population. Inappropriate prescribing of antidepressants can increase the risk for poor outcomes offsetting any benefit to their use. Unfortunately, clinical trials of the use of antidepressants in the elderly are underrepresented with confusing outcomes on the long-term effects. The emergence and/or treatment of dementia associated with elders’ antidepressant treatment is central to providing care. This program examines the myths, traditional practices, and evidence on the use of all antidepressants prescribed to the elderly. This program reviews the evidence drawn from systematic reviews and the evidence-based practice standards. Included is a review of dosing, adverse events, and preventative best practices on the use of all antidepressants being given to those over age 65.
Presenter: Michael Rice, PhD, APRN, FAAN
For complete details visit: https://education.smiadviser.org/diweb/catalog/item?id=6513209